Reaction
Growth Hormone Deficiency reporting signals
As of the last recalculation, Growth Hormone Deficiency appears in 393 FAERS reports alongside 7 co-occurring drug terms. The strongest observed disproportionality signal is LANREOTIDE ACETATE (PRR 219.3).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Lanreotide Acetate | 30 | 219.3 | 220.2 |
| Quetiapine Fumarate | 57 | 119.5 | 119.7 |
| Thiotepa | 15 | 86.5 | 86.6 |
| Somatropin | 55 | 45.9 | 46.0 |
| Busulfan | 13 | 45.2 | 45.3 |
| Cladribine | 5 | 27.9 | 27.9 |
| Asfotase Alfa | 4 | 21.4 | 21.4 |